September 4th 2025
The therapy from Boehringer Ingelheim provides protection against porcine circovirus type 2.
UN, WHO address public health concern over avian flu transmission to humans
April 18th 2024Veterinary professionals working with certain animals are advised to take precautionary steps to minimize risk of infection, while researchers in Texas study potential H5N1 vaccines, antivirals, and antibody therapies for humans